You can buy or sell Kadmon and other stocks, options, ETFs, and crypto commission-free!
Kadmon Holdings, Inc., also called Kadmon, is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. It focuses on the treatment of autoimmune, inflammatory, and fibrotic diseases. Read More Its products include Ribasphere, RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Yahoo FinanceMay 9
Kadmon Provides Business Update and Reports First Quarter 2019 Financial Results
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / Kadmon Holdings, Inc. (KDMN) today provided a business update and reported financial and operational results for the first quarter of 2019. ''The advancement of KD025 for the treatment of cGVHD continues to be Kadmon's key priority. We recently held a Type B Breakthrough Therapy meeting with the FDA and remain aligned with the Agency on our registration study design and the broader data package to support a potential New Drug Application,'' said Harlan W. Waksal, M...
-$0.16 per share
$0.02 per share